Back
Take-Two Interactive Software Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
51
TTWO
Take-Two Interactive Software
Last Price:
177.88
Seasonality Move:
4.88%
Buy
59
ANIP
ANI Pharmaceuticals
Last Price:
61.42
Seasonality Move:
5.08%
Buy
51
Take-Two Interactive Software (TTWO)
is a Buy
Is Take-Two Interactive Software a Buy, Sell or Hold?
- The current Take-Two Interactive Software [TTWO] share price is $177.90. The Score for TTWO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- TTWO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.67. The Score for ANIP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TTWO Stock Price Chart
What is Take-Two Interactive Software's stock price today?
-
The Take-Two Interactive Software share price today is $177.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TTWO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
TTWO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.82 | Buy |
| Relative Strength Index (14 RSI): | 80.3 | Buy |
| Chaikin Money Flow: | 1169663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (153.32 - 167) | Buy |
| Bollinger Bands (100): | (147.56 - 160.86) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 60.46 | Buy |
| Chaikin Money Flow: | 225492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.73 - 59.67) | Buy |
| Bollinger Bands (100): | (57.7 - 62.92) | Buy |
TTWO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 167.39 | Buy |
| 20-day SMA: | 161.99 | Buy |
| 50-day SMA: | 156.87 | Buy |
| 200-day SMA: | 153.07 | Buy |
| 8-day EMA: | 169.28 | Buy |
| 20-day EMA: | 163.54 | Buy |
| 50-day EMA: | 158.46 | Buy |
| 200-day EMA: | 152.93 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.22 | Buy |
| 20-day SMA: | 58.64 | Buy |
| 50-day SMA: | 58.71 | Buy |
| 200-day SMA: | 62.04 | Sell |
| 8-day EMA: | 58.8 | Buy |
| 20-day EMA: | 58.52 | Buy |
| 50-day EMA: | 58.98 | Buy |
| 200-day EMA: | 59.88 | Buy |
Take-Two Interactive Software Earnings Growth & TTWO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.87 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.29 per share, and an increase next year of $0.25 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.82 per share.
Take-Two Interactive Software Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||